Our Mission
At Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. We help prepare communities for today’s health challenges and tomorrow’s threats by:
- Empowering the public with the resources to respond to an opioid overdose emergency
- Delivering medical countermeasures to fight critical, even deadly, biological threats
- Stepping up to help address emerging and infectious diseases
Our History
Emergent opened for business, partnering with the U.S. government to supply BioThrax (Anthrax Vaccine Absorbed) for military members.
Emergent BioSolutions common stock begins trading on the New York Stock Exchange ($EBS).
Received funding for CYFENDUS® (Anthrax Vaccine Absorbed, Adjuvanted) from the Biomedical Advanced Research and Development Authority (BARDA) and National Institute of Allergy and Infectious Diseases (NIAID).
Acquired rights to auto-injector technology, growing our devices business.
Acquired NARCAN® Nasal Spray (naloxone HCl).
Our Culture and Values
Our culture is informed by our values and commitment to protecting and saving lives. For all the people touched by our work, we operate with an unwavering commitment to honesty, integrity, and quality.